Company Information
About Novo Nordisk
Located in Princeton, New Jersey, Novo Nordisk Inc. has more than 4,000 employees handling sales and marketing activities, along with medical, IT, regulatory, financial, and human resources responsibilities. We're the United States affiliate of Novo Nordisk A/S, Copenhagen, Denmark. And at our manufacturing facility in Clayton, North Carolina, more than 350 employees supply insulin to the United States diabetes market and throughout the world. >> Read More
Healthcare innovations
Novo Nordisk affiliates strive to enhance the health and quality of life for people throughout the world. For 80 years, Novo Nordisk has combined drug discovery with state-of-the-art technology to turn science into solutions for people with diabetes, people with hemophilia, children with growth hormone deficiency, and women experiencing the symptoms of menopause. Our commitment to diabetes research is reflected in our variety of insulin products, other medical solutions, and the many exciting new treatment options in our pipeline. At Novo Nordisk, committed people with expertise in a variety of areas work together to develop pharmaceuticals, advanced devices, and customized services. >> Read More
Our people
Why do we remain a world leader? Perhaps it's the diversity of our staff, our commitment to people, and our wealth of industry innovation, experience, and ideas. Our winning culture is focused on cross-functional and cross-cultural teamwork. This culture combines clinical research, sales and marketing, and the legal and regulatory efforts that protect the safety of our customers. People are the driving force behind Novo Nordisk. >> Read More
Alliances
In the United States, we have a strategic alliance with the Mayo Clinic to improve the management of diabetes, and we currently hold licensing or collaboration agreements with other leading healthcare companies. Internationally, we have fostered partnerships with the Oxford Center for Diabetes, Endocrinology and Metabolism in the United Kingdom, and are working on research initiatives with the European Association for the Study of Diabetes (EASD) and the Juvenile Diabetes Research Foundation International (JDRF). >> Read More
